EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drugs and chemical substances inducing diabetes - review of the literature

Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska

Prospects in Pharmaceutical Sciences · 06.05.2024 · 22 (2) · 7-17

DOI: 10.56782/pps.183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prospects in Pharmaceutical Sciences, online erschienen am 06.05.2024. Verfasst von Paulina Oleksa und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Type 3 of diabetes, classified as secondary diabetes, includes drug-induced or chemical-induced forms of diabetes. We distinguish many types of drugs that can indicate diabetes, among others commonly used glucocorticosteroids, β-blockers and diuretics, antidepressants and antipsychotics, statins, antiviral drugs. We aimed to evaluate the impact of chosen drugs and chemical substances on glycemic control, to analyse the mechanisms of development of drug-induced diabetes and to propose the therapeutic procedures. We conducted the literature review from the last 10 years using the Pubmed and Google Scholar. We analysed reviews, systematic reviews, meta-analysis, randomized controlled trials, clinical trials, observational studies published from 2013 to 2023. Mechanisms of diabetes development are various and complex. However, we need to underline the role of drug-induced weight gain. The duration of therapy is also important because longer therapy is usually associated with higher risk of development of diabetes. Drug-induced diabetes is a significant clinical problem. The benefits of using the drug often outweigh the side effects associated with poor glycemic control. Currently, pharmacotherapy of drug-induced diabetes is similar to the standards of treatment for other types of diabetes. Changing therapy to the drug with lower metabolic risk should be considered as far as possible.

Zitieren

APA

Oleksa, P., Żuraw, D., Jasiński, K., Sobczyk, M., Porzak, M., Sodolska, A., & Haczkur-Pawłowska, K. (2024). Drugs and chemical substances inducing diabetes - review of the literature. Prospects in Pharmaceutical Sciences, 22(2), 7-17. https://doi.org/10.56782/pps.183

Vancouver

Oleksa P, Żuraw D, Jasiński K, Sobczyk M, Porzak M, Sodolska A, et al. Drugs and chemical substances inducing diabetes - review of the literature. Prospects in Pharmaceutical Sciences. 2024;22(2):7-17. doi:10.56782/pps.183

BibTeX
@article{Oleksa2024,
  author = {Oleksa, Paulina and Żuraw, Daria and Jasiński, Kacper and Sobczyk, Mateusz and Porzak, Mikołaj and Sodolska, Alicja and Haczkur-Pawłowska, Karolina},
  title = {Drugs and chemical substances inducing diabetes - review of the literature},
  journal = {Prospects in Pharmaceutical Sciences},
  year = {2024},
  volume = {22},
  number = {2},
  pages = {7--17},
  doi = {10.56782/pps.183}
}
Kostenlos starten →